SAN DIEGO, Jan. 30, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that it has been named one of three top hemp producers of 2018 by MMJ Reporter.
According to a report by the Hemp Business Journal, the hemp industry is projected to grow 700% and hit $1.8 billion by 2020. This includes cannabidiol (CBD) derived from the industrial hemp plant, an all-natural, non-psychoactive supplement that helps boost both human and animal endocannabinoid systems.
Medical Marijuana, Inc. has become one of the most respected and recognized leaders in the CBD hemp oil market because of its flagship product Real Scientific Hemp Oil™ (RSHO™), which is now being subsidized by the Brazilian government and exported into several other Latin American countries such as Mexico and even as a medicine in Paraguay. In 2017, the Company experienced year-over-year growth of more than 300% compared to 2016.
“We are honored to receive such prestigious recognition for the hard work we continuously put into being a pioneer for excellence in the hemp and cannabis industries,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We believe that the future of hemp looks incredibly bright and we hope to set an example for the quality and testing standards needed to produce the best CBD hemp oil products.”
In 2018, Medical Marijuana, Inc. will be excited to announce many new CBD hemp oil products under its subsidiaries Kannaway®, HempMeds® and Phyto Animal Health and help promote access to CBD hemp oil across the globe.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer CMW Media